SWOT Analysis for C4 Therapeutics Inc

Relative Outperformance versus Industry over 1 Week
Significant (over 30%) distance from 52 week high
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Relative Outperformance versus Industry over 1 Week
Company with Low Debt
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Stock with Low PE (PE < = 10)
Volume Shockers

Stocks with Quarter Change % less than Industry
Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score
Low DVM Stocks - Stocks to Exercise Caution On
Lowest Momentum Scores (Technical Scores)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Low durability companies
Weak Stocks (DVM)
Highest fall from 52 Week High
Top Losers
Low Piotroski Score : Companies with weak financials
Declining Net Cash Flow : Companies not able to generate net cash
Book Value Per Share deteriorating for last 2 years
Weak performer : Stock lost more than 20% in 1 month
Weak Momentum: Price below Short, Medium and Long Term Averages
Declining profits every quarter for the past 2 quarters
RSI indicating price weakness
Near 52 Week Low
Top Losers
Stocks Underperforming their Industry Price Change in the Quarter